SCHEMBL24629464

SCHEMBL24629464

CN1CCC(C(C)(C)N)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL782872 0.83 MAPK1 (0.31) —
SCHEMBL22743944 0.83 MAPK1 (0.31) —
SCHEMBL28251386 0.77 MAPK1 (0.30) —
SCHEMBL24451121 0.71 BRD4 (0.37) —
SCHEMBL24629577 0.71 ACE (0.30) —
SCHEMBL13036914 0.69 BRD4 (0.35) —
SCHEMBL5997698 0.69 — —
SCHEMBL21722626 0.69 — —
SCHEMBL75546 0.69 — —
SCHEMBL3183061 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022150707-A1 FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF Tabomedex Biosciences, Inc. (US) 2022-07-14 — — WO disclosed
Send feedback